Metabolic studies and preclinical evaluation of priority 19/18F-molecules

OXF and JAN will generate a number of novel 19F- and 18F-fluorinated fragments and molecules, for which metabolic stability is unclear or unknown, and will require systematic investigation. All ESRs will be involved.